In fact, activated macrophages has an established role in feeding the inflammatory milieu at the synovium site in RA, leading to bone remodeling and erosions; indeed drugs targeting inflammatory cytokines such as TNF, IL-1, and IL-6 have a significative impact on osteoclastogenesis and prevent generalized and local bone loss. This evidence concerns the gene TNF and rheumatoid arthritis.